EPO Patents = 6

Forward Citations = 33

Loading Chart...

8 inventors (with patents filed for the assignee):

Katsuto Tamai (4 out of 16 patents)

Takehiko Yamazaki (4 out of 13 patents)

Yasufumi Kaneda (3 out of 25 patents)

4. Takenao Chino (2 out of 4 patents)

5. Yoshiki Sawa (1 out of 20 patents)

6. Shigeru Miyagawa (1 out of 13 patents)

7. Wenhao Cui (1 out of 1 patent)

8. Sokichi Kamata (1 out of 1 patent)

9. Mayumi Endo (3 patents)

10. Tsutomu Kanezaki (2 patents)

11. Shigeru Sakurai (2 patents)

12. Yukiko Noguchi (2 patents)

13. Natsumi Hamabuchi (2 patents)

14. Kana Naito (2 patents)

15. Kotaro Saga (2 patents)

4 patents: Sort by Forward Citations

1. 9919010 - Method for collecting functional cells in vivo with high efficiency (2018-03-20),

2. 9688733 - Method for treating spinal cord injury using HMGB1 fragment (2017-06-27),

3. 9623078 - Method for treating cardiac infarction using HMGB1 fragment (2017-04-18),

4. 8673580 - Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation (2014-03-18),

Genomix Co., Ltd. is a leading biotechnology company specializing in genetic testing and personalized medicine. We offer innovative solutions for healthcare providers, pharmaceutical companies, and research institutions. Our advanced technology and expertise in genomics allow us to provide accurate and reliable genetic testing services for various applications. With a commitment to improving patient outcomes and advancing personalized medicine, Genomix is dedicated to driving innovation in the field of genetics.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

4 Patents

#708 in Osaka

#7,424 in Japan

Osaka, Japan

Genomix Co., Ltd.